세계의 백신 시장예측 2020년-2025년

■ 영문 제목 : Global All Vaccine Market Growth 2020-2025

LP Information 회사가 출판한 조사자료로, 코드는 LPI20KJU00316 입니다.■ 상품코드 : LPI20KJU00316
■ 조사/발행회사 : LP Information
■ 발행일 : 2020년5월15일
■ 페이지수 : 161
■ 작성언어 : 영어
■ 보고서 형태 : PDF
■ 납품 방식 : E메일
■ 조사대상 지역 : 글로벌
■ 산업 분야 : 의료, 제약
■ 판매가격 / 옵션 (부가세별도)
Single User (1명 열람용)USD3,660 ⇒환산₩4,099,200견적의뢰/주문/질문
Multi User (5명 열람용)USD5,490 ⇒환산₩6,148,800견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)USD7,320 ⇒환산₩8,198,400견적의뢰/구입/질문
가격옵션 설명
- 지불하실 금액은 상기 원화금액에 부가세(10%)를 더한 금액입니다.
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제이며, 세금계산서 발행 가능합니다.
본 조사보고서는 백신의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측, 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 각지역의 종류별 시장규모 (Varicella, Influenza, Polio, Hepatitis A, Rabies, BCG, Hepatitis B, Pertussis, Diphtheria, tetanus, Pneumococcal)와 용도별 시장규모 (For Adult, For Child) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 백신 시장 점유율
- 지역별 백신 시장규모
- 각지역의 종류별 시장규모 (Varicella, Influenza, Polio, Hepatitis A, Rabies, BCG, Hepatitis B, Pertussis, Diphtheria, tetanus, Pneumococcal)
- 각지역의 용도별 시장규모 (For Adult, For Child)
- 미주의 백신 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 백신 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 백신 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 백신 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 백신 시장예측 (2021년-2025년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
- 조사의 결과/결론
■ 보고서 개요

COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.

According to this latest study, the 2020 growth of All Vaccine will have significant change from previous year. By the most conservative estimates of global All Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the All Vaccine market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of All Vaccine market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the All Vaccine, covering the supply chain analysis, impact assessment to the All Vaccine market size growth rate in several scenarios, and the measures to be undertaken by All Vaccine companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Varicella
Influenza
Polio
Hepatitis A
Rabies
BCG
Hepatitis B
Pertussis, Diphtheria, tetanus
Pneumococcal

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
For Adult
For Child

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
CNBG
Novartis
ChengDa Bio
Zhifei
SINOVAC BIOTECH
Changsheng Life
Kangtai
NuoCheng Bio
SANOFI PASTEUR
Hualan Bio
GSK

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global All Vaccine consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of All Vaccine market by identifying its various subsegments.
Focuses on the key global All Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the All Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of All Vaccine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 What is the Impact of Covid-19 Outbreak On the All Vaccine?
1.8.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.
1.8.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.
1.8.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global All Vaccine Market Size in 2020, by Scenario
1.8.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now

2 Executive Summary
2.1 World Market Overview
2.1.1 Global All Vaccine Consumption 2015-2025
2.1.2 All Vaccine Consumption CAGR by Region
2.2 All Vaccine Segment by Type
2.2.1 Varicella
2.2.2 Influenza
2.2.3 Polio
2.2.4 Hepatitis A
2.2.5 Rabies
2.2.6 BCG
2.2.7 Hepatitis B
2.2.8 Pertussis, Diphtheria, tetanus
2.2.9 Pneumococcal
2.2.10 Others
2.3 All Vaccine Consumption by Type
2.3.1 Global All Vaccine Consumption Market Share by Type (2015-2020)
2.3.2 Global All Vaccine Revenue and Market Share by Type (2015-2020)
2.3.3 Global All Vaccine Sale Price by Type (2015-2020)
2.4 All Vaccine Segment by Application
2.4.1 For Adult
2.4.2 For Child
2.5 All Vaccine Consumption by Application
2.5.1 Global All Vaccine Consumption Market Share by Type (2015-2020)
2.5.2 Global All Vaccine Value and Market Share by Type (2015-2020)
2.5.3 Global All Vaccine Sale Price by Type (2015-2020)

3 Global All Vaccine by Company
3.1 Global All Vaccine Sales Market Share by Company
3.1.1 Global All Vaccine Sales by Company (2018-2020)
3.1.2 Global All Vaccine Sales Market Share by Company (2018-2020)
3.2 Global All Vaccine Revenue Market Share by Company
3.2.1 Global All Vaccine Revenue by Company (2018-2020)
3.2.2 Global All Vaccine Revenue Market Share by Company (2018-2020)
3.3 Global All Vaccine Sale Price by Company
3.4 Global All Vaccine Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global All Vaccine Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players All Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 All Vaccine by Regions
4.1 All Vaccine by Regions
4.2 Americas All Vaccine Consumption Growth
4.3 APAC All Vaccine Consumption Growth
4.4 Europe All Vaccine Consumption Growth
4.5 Middle East & Africa All Vaccine Consumption Growth

5 Americas
5.1 Americas All Vaccine Consumption by Countries
5.1.1 Americas All Vaccine Consumption by Countries (2015-2020)
5.1.2 Americas All Vaccine Value by Countries (2015-2020)
5.2 Americas All Vaccine Consumption by Type
5.3 Americas All Vaccine Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC All Vaccine Consumption by Regions
6.1.1 APAC All Vaccine Consumption by Regions (2015-2020)
6.1.2 APAC All Vaccine Value by Regions (2015-2020)
6.2 APAC All Vaccine Consumption by Type
6.3 APAC All Vaccine Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe All Vaccine by Countries
7.1.1 Europe All Vaccine Consumption by Countries (2015-2020)
7.1.2 Europe All Vaccine Value by Countries (2015-2020)
7.2 Europe All Vaccine Consumption by Type
7.3 Europe All Vaccine Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa All Vaccine by Countries
8.1.1 Middle East & Africa All Vaccine Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa All Vaccine Value by Countries (2015-2020)
8.2 Middle East & Africa All Vaccine Consumption by Type
8.3 Middle East & Africa All Vaccine Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 All Vaccine Distributors
10.3 All Vaccine Customer

11 Global All Vaccine Market Forecast
11.1 Global All Vaccine Consumption Forecast (2021-2025)
11.2 Global All Vaccine Forecast by Regions
11.2.1 Global All Vaccine Forecast by Regions (2021-2025)
11.2.2 Global All Vaccine Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global All Vaccine Forecast by Type
11.8 Global All Vaccine Forecast by Application

12 Key Players Analysis
12.1 CNBG
12.1.1 Company Information
12.1.2 All Vaccine Product Offered
12.1.3 CNBG All Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 CNBG Latest Developments
12.2 Novartis
12.2.1 Company Information
12.2.2 All Vaccine Product Offered
12.2.3 Novartis All Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Novartis Latest Developments
12.3 ChengDa Bio
12.3.1 Company Information
12.3.2 All Vaccine Product Offered
12.3.3 ChengDa Bio All Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 ChengDa Bio Latest Developments
12.4 Zhifei
12.4.1 Company Information
12.4.2 All Vaccine Product Offered
12.4.3 Zhifei All Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Zhifei Latest Developments
12.5 SINOVAC BIOTECH
12.5.1 Company Information
12.5.2 All Vaccine Product Offered
12.5.3 SINOVAC BIOTECH All Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 SINOVAC BIOTECH Latest Developments
12.6 Changsheng Life
12.6.1 Company Information
12.6.2 All Vaccine Product Offered
12.6.3 Changsheng Life All Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Changsheng Life Latest Developments
12.7 Kangtai
12.7.1 Company Information
12.7.2 All Vaccine Product Offered
12.7.3 Kangtai All Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Kangtai Latest Developments
12.8 NuoCheng Bio
12.8.1 Company Information
12.8.2 All Vaccine Product Offered
12.8.3 NuoCheng Bio All Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 NuoCheng Bio Latest Developments
12.9 SANOFI PASTEUR
12.9.1 Company Information
12.9.2 All Vaccine Product Offered
12.9.3 SANOFI PASTEUR All Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 SANOFI PASTEUR Latest Developments
12.10 Hualan Bio
12.10.1 Company Information
12.10.2 All Vaccine Product Offered
12.10.3 Hualan Bio All Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Hualan Bio Latest Developments
12.11 GSK
12.11.1 Company Information
12.11.2 All Vaccine Product Offered
12.11.3 GSK All Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 GSK Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global All Vaccine Market Size in 2020, by Scenario
Table 2. COVID-19: Measures to be Undertaken by All Vaccine Companies
Table 3. Research Methodology
Table 4. Data Source
Table 5. All Vaccine Consumption CAGR by Region 2015-2025 ($ Millions)
Table 6. Major Players of Varicella
Table 7. Major Players of Influenza
Table 8. Major Players of Polio
Table 9. Major Players of Hepatitis A
Table 10. Major Players of Rabies
Table 11. Major Players of BCG
Table 12. Major Players of Hepatitis B
Table 13. Major Players of Pertussis, Diphtheria, tetanus
Table 14. Major Players of Pneumococcal
Table 15. Major Players of Others
Table 16. Global Consumption Sales by Type (2015-2020)
Table 17. Global All Vaccine Consumption Market Share by Type (2015-2020)
Table 18. Global All Vaccine Revenue by Type (2015-2020) ($ million)
Table 19. Global All Vaccine Value Market Share by Type (2015-2020) ($ Millions)
Table 20. Global All Vaccine Sale Price by Type (2015-2020)
Table 21. Global Consumption Sales by Application (2015-2020)
Table 22. Global All Vaccine Consumption Market Share by Application (2015-2020)
Table 23. Global All Vaccine Value by Application (2015-2020)
Table 24. Global All Vaccine Value Market Share by Application (2015-2020)
Table 25. Global All Vaccine Sale Price by Application (2015-2020)
Table 26. Global All Vaccine Sales by Company (2017-2019) (M Dose)
Table 27. Global All Vaccine Sales Market Share by Company (2017-2019)
Table 28. Global All Vaccine Revenue by Company (2017-2019) ($ Millions)
Table 29. Global All Vaccine Revenue Market Share by Company (2017-2019)
Table 30. Global All Vaccine Sale Price by Company (2017-2019)
Table 31. Global All Vaccine Manufacturing Base Distribution and Sales Area by Manufacturers
Table 32. Players All Vaccine Products Offered
Table 33. All Vaccine Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 34. Global All Vaccine Consumption by Regions 2015-2020 (M Dose)
Table 35. Global All Vaccine Consumption Market Share by Regions 2015-2020
Table 36. Global All Vaccine Value by Regions 2015-2020 ($ Millions)
Table 37. Global All Vaccine Value Market Share by Regions 2015-2020
Table 38. Americas All Vaccine Consumption by Countries (2015-2020) (M Dose)
Table 39. Americas All Vaccine Consumption Market Share by Countries (2015-2020)
Table 40. Americas All Vaccine Value by Countries (2015-2020) ($ Millions)
Table 41. Americas All Vaccine Value Market Share by Countries (2015-2020)
Table 42. Americas All Vaccine Consumption by Type (2015-2020) (M Dose)
Table 43. Americas All Vaccine Consumption Market Share by Type (2015-2020)
Table 44. Americas All Vaccine Consumption by Application (2015-2020) (M Dose)
Table 45. Americas All Vaccine Consumption Market Share by Application (2015-2020)
Table 46. APAC All Vaccine Consumption by Countries (2015-2020) (M Dose)
Table 47. APAC All Vaccine Consumption Market Share by Countries (2015-2020)
Table 48. APAC All Vaccine Value by Regions (2015-2020) ($ Millions)
Table 49. APAC All Vaccine Value Market Share by Regions (2015-2020)
Table 50. APAC All Vaccine Consumption by Type (2015-2020) (M Dose)
Table 51. APAC All Vaccine Consumption Market Share by Type (2015-2020)
Table 52. APAC All Vaccine Consumption by Application (2015-2020) (M Dose)
Table 53. APAC All Vaccine Consumption Market Share by Application (2015-2020)
Table 54. Europe All Vaccine Consumption by Countries (2015-2020) (M Dose)
Table 55. Europe All Vaccine Consumption Market Share by Countries (2015-2020)
Table 56. Europe All Vaccine Value by Countries (2015-2020) ($ Millions)
Table 57. Europe All Vaccine Value Market Share by Countries (2015-2020)
Table 58. Europe All Vaccine Consumption by Type (2015-2020) (M Dose)
Table 59. Europe All Vaccine Consumption Market Share by Type (2015-2020)
Table 60. Europe All Vaccine Consumption by Application (2015-2020) (M Dose)
Table 61. Europe All Vaccine Consumption Market Share by Application (2015-2020)
Table 62. Middle East & Africa All Vaccine Consumption by Countries (2015-2020) (M Dose)
Table 63. Middle East & Africa All Vaccine Consumption Market Share by Countries (2015-2020)
Table 64. Middle East & Africa All Vaccine Value by Countries (2015-2020) ($ Millions)
Table 65. Middle East & Africa All Vaccine Value Market Share by Countries (2015-2020)
Table 66. Middle East & Africa All Vaccine Consumption by Type (2015-2020) (M Dose)
Table 67. Middle East & Africa All Vaccine Consumption Market Share by Type (2015-2020)
Table 68. Middle East & Africa All Vaccine Consumption by Application (2015-2020) (M Dose)
Table 69. Middle East & Africa All Vaccine Consumption Market Share by Application (2015-2020)
Table 70. All Vaccine Distributors List
Table 71. All Vaccine Customer List
Table 72. Global All Vaccine Consumption Forecast by Countries (2021-2025) (M Dose)
Table 73. Global All Vaccine Consumption Market Forecast by Regions
Table 74. Global All Vaccine Value Forecast by Countries (2021-2025) ($ Millions)
Table 75. Global All Vaccine Value Market Share Forecast by Regions
Table 76. Global All Vaccine Consumption Forecast by Type (2021-2025) (M Dose)
Table 77. Global All Vaccine Consumption Market Share Forecast by Type (2021-2025)
Table 78. Global All Vaccine Value Forecast by Type (2021-2025) ($ Millions)
Table 79. Global All Vaccine Value Market Share Forecast by Type (2021-2025)
Table 80. Global All Vaccine Consumption Forecast by Application (2021-2025) (M Dose)
Table 81. Global All Vaccine Consumption Market Share Forecast by Application (2021-2025)
Table 82. Global All Vaccine Value Forecast by Application (2021-2025) ($ Millions)
Table 83. Global All Vaccine Value Market Share Forecast by Application (2021-2025)
Table 84. CNBG Product Offered
Table 85. CNBG All Vaccine Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 86. CNBG Main Business
Table 87. CNBG Latest Developments
Table 88. CNBG Basic Information, Company Total Revenue (in $ million), All Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Novartis Product Offered
Table 90. Novartis All Vaccine Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 91. Novartis Main Business
Table 92. Novartis Latest Developments
Table 93. Novartis Basic Information, Company Total Revenue (in $ million), All Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. ChengDa Bio Product Offered
Table 95. ChengDa Bio All Vaccine Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 96. ChengDa Bio Main Business
Table 97. ChengDa Bio Latest Developments
Table 98. ChengDa Bio Basic Information, Company Total Revenue (in $ million), All Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. Zhifei Product Offered
Table 100. Zhifei All Vaccine Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 101. Zhifei Main Business
Table 102. Zhifei Latest Developments
Table 103. Zhifei Basic Information, Company Total Revenue (in $ million), All Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. SINOVAC BIOTECH Product Offered
Table 105. SINOVAC BIOTECH All Vaccine Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 106. SINOVAC BIOTECH Main Business
Table 107. SINOVAC BIOTECH Latest Developments
Table 108. SINOVAC BIOTECH Basic Information, Company Total Revenue (in $ million), All Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Changsheng Life Product Offered
Table 110. Changsheng Life All Vaccine Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 111. Changsheng Life Main Business
Table 112. Changsheng Life Latest Developments
Table 113. Changsheng Life Basic Information, Company Total Revenue (in $ million), All Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. Kangtai Product Offered
Table 115. Kangtai Basic Information, Company Total Revenue (in $ million), All Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 116. Kangtai Main Business
Table 117. Kangtai Latest Developments
Table 118. Kangtai All Vaccine Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 119. NuoCheng Bio Product Offered
Table 120. NuoCheng Bio All Vaccine Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 121. NuoCheng Bio Main Business
Table 122. NuoCheng Bio Latest Developments
Table 123. NuoCheng Bio Basic Information, Company Total Revenue (in $ million), All Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 124. SANOFI PASTEUR Product Offered
Table 125. SANOFI PASTEUR All Vaccine Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 126. SANOFI PASTEUR Main Business
Table 127. SANOFI PASTEUR Latest Developments
Table 128. SANOFI PASTEUR Basic Information, Company Total Revenue (in $ million), All Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 129. Hualan Bio Product Offered
Table 130. Hualan Bio All Vaccine Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 131. Hualan Bio Main Business
Table 132. Hualan Bio Latest Developments
Table 133. Hualan Bio Basic Information, Company Total Revenue (in $ million), All Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 134. GSK Product Offered
Table 135. GSK All Vaccine Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 136. GSK Main Business
Table 137. GSK Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 138. GSK Latest Developments
List of Figures
Figure 1. Picture of All Vaccine
Figure 2. All Vaccine Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global All Vaccine Consumption Growth Rate 2015-2025 (M Dose)
Figure 5. Global All Vaccine Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Varicella
Figure 7. Product Picture of Influenza
Figure 8. Product Picture of Polio
Figure 9. Product Picture of Hepatitis A
Figure 10. Product Picture of Rabies
Figure 11. Product Picture of BCG
Figure 12. Product Picture of Hepatitis B
Figure 13. Product Picture of Pertussis, Diphtheria, tetanus
Figure 14. Product Picture of Pneumococcal
Figure 15. Product Picture of Others
Figure 16. Global All Vaccine Consumption Market Share by Type (2015-2020)
Figure 17. Global All Vaccine Value Market Share by Type (2015-2020)
Figure 18. All Vaccine Consumed in For Adult
Figure 19. Global All Vaccine Market: For Adult (2015-2020) (M Dose)
Figure 20. Global All Vaccine Market: For Adult (2015-2020) ($ Millions)
Figure 21. All Vaccine Consumed in For Child
Figure 22. Global All Vaccine Market: For Child (2015-2020) (M Dose)
Figure 23. Global All Vaccine Market: For Child (2015-2020) ($ Millions)
Figure 24. Global All Vaccine Consumption Market Share by Application (2015-2020)
Figure 25. Global All Vaccine Value Market Share by Application (2015-2020)
Figure 26. Global All Vaccine Sales Market Share by Company in 2017
Figure 27. Global All Vaccine Sales Market Share by Company in 2019
Figure 28. Global All Vaccine Revenue Market Share by Company in 2017
Figure 29. Global All Vaccine Revenue Market Share by Company in 2019
Figure 30. Global All Vaccine Sale Price by Company in 2019
Figure 31. Global All Vaccine Consumption Market Share by Regions 2015-2020
Figure 32. Global All Vaccine Value Market Share by Regions 2015-2020
Figure 33. Americas All Vaccine Consumption 2015-2020 (M Dose)
Figure 34. Americas All Vaccine Value 2015-2020 ($ Millions)
Figure 35. APAC All Vaccine Consumption 2015-2020 (M Dose)
Figure 36. APAC All Vaccine Value 2015-2020 ($ Millions)
Figure 37. Europe All Vaccine Consumption 2015-2020 (M Dose)
Figure 38. Europe All Vaccine Value 2015-2020 ($ Millions)
Figure 39. Middle East & Africa All Vaccine Consumption 2015-2020 (M Dose)
Figure 40. Middle East & Africa All Vaccine Value 2015-2020 ($ Millions)
Figure 41. Americas All Vaccine Consumption Market Share by Countries in 2019
Figure 42. Americas All Vaccine Value Market Share by Countries in 2019
Figure 43. Americas All Vaccine Consumption Market Share by Type in 2019
Figure 44. Americas All Vaccine Consumption Market Share by Application in 2019
Figure 45. United States All Vaccine Consumption Growth 2015-2020 (M Dose)
Figure 46. United States All Vaccine Value Growth 2015-2020 ($ Millions)
Figure 47. Canada All Vaccine Consumption Growth 2015-2020 (M Dose)
Figure 48. Canada All Vaccine Value Growth 2015-2020 ($ Millions)
Figure 49. Mexico All Vaccine Consumption Growth 2015-2020 (M Dose)
Figure 50. Mexico All Vaccine Value Growth 2015-2020 ($ Millions)
Figure 51. APAC All Vaccine Consumption Market Share by Countries in 2019
Figure 52. APAC All Vaccine Value Market Share by Regions in 2019
Figure 53. APAC All Vaccine Consumption Market Share by Type in 2019
Figure 54. APAC All Vaccine Consumption Market Share by Application in 2019
Figure 55. China All Vaccine Consumption Growth 2015-2020 (M Dose)
Figure 56. China All Vaccine Value Growth 2015-2020 ($ Millions)
Figure 57. Japan All Vaccine Consumption Growth 2015-2020 (M Dose)
Figure 58. Japan All Vaccine Value Growth 2015-2020 ($ Millions)
Figure 59. Korea All Vaccine Consumption Growth 2015-2020 (M Dose)
Figure 60. Korea All Vaccine Value Growth 2015-2020 ($ Millions)
Figure 61. Southeast Asia All Vaccine Consumption Growth 2015-2020 (M Dose)
Figure 62. Southeast Asia All Vaccine Value Growth 2015-2020 ($ Millions)
Figure 63. India All Vaccine Consumption Growth 2015-2020 (M Dose)
Figure 64. India All Vaccine Value Growth 2015-2020 ($ Millions)
Figure 65. Australia All Vaccine Consumption Growth 2015-2020 (M Dose)
Figure 66. Australia All Vaccine Value Growth 2015-2020 ($ Millions)
Figure 67. Europe All Vaccine Consumption Market Share by Countries in 2019
Figure 68. Europe All Vaccine Value Market Share by Countries in 2019
Figure 69. Europe All Vaccine Consumption Market Share by Type in 2019
Figure 70. Europe All Vaccine Consumption Market Share by Application in 2019
Figure 71. Germany All Vaccine Consumption Growth 2015-2020 (M Dose)
Figure 72. Germany All Vaccine Value Growth 2015-2020 ($ Millions)
Figure 73. France All Vaccine Consumption Growth 2015-2020 (M Dose)
Figure 74. France All Vaccine Value Growth 2015-2020 ($ Millions)
Figure 75. UK All Vaccine Consumption Growth 2015-2020 (M Dose)
Figure 76. UK All Vaccine Value Growth 2015-2020 ($ Millions)
Figure 77. Italy All Vaccine Consumption Growth 2015-2020 (M Dose)
Figure 78. Italy All Vaccine Value Growth 2015-2020 ($ Millions)
Figure 79. Russia All Vaccine Consumption Growth 2015-2020 (M Dose)
Figure 80. Russia All Vaccine Value Growth 2015-2020 ($ Millions)
Figure 81. Middle East & Africa All Vaccine Consumption Market Share by Countries in 2019
Figure 82. Middle East & Africa All Vaccine Value Market Share by Countries in 2019
Figure 83. Middle East & Africa All Vaccine Consumption Market Share by Type in 2019
Figure 84. Middle East & Africa All Vaccine Consumption Market Share by Application in 2019
Figure 85. Egypt All Vaccine Consumption Growth 2015-2020 (M Dose)
Figure 86. Egypt All Vaccine Value Growth 2015-2020 ($ Millions)
Figure 87. South Africa All Vaccine Consumption Growth 2015-2020 (M Dose)
Figure 88. South Africa All Vaccine Value Growth 2015-2020 ($ Millions)
Figure 89. Israel All Vaccine Consumption Growth 2015-2020 (M Dose)
Figure 90. Israel All Vaccine Value Growth 2015-2020 ($ Millions)
Figure 91. Turkey All Vaccine Consumption Growth 2015-2020 (M Dose)
Figure 92. Turkey All Vaccine Value Growth 2015-2020 ($ Millions)
Figure 93. GCC Countries All Vaccine Consumption Growth 2015-2020 (M Dose)
Figure 94. GCC Countries All Vaccine Value Growth 2015-2020 ($ Millions)
Figure 95. Global All Vaccine Consumption Growth Rate Forecast (2021-2025) (M Dose)
Figure 96. Global All Vaccine Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 97. Americas All Vaccine Consumption 2021-2025 (M Dose)
Figure 98. Americas All Vaccine Value 2021-2025 ($ Millions)
Figure 99. APAC All Vaccine Consumption 2021-2025 (M Dose)
Figure 100. APAC All Vaccine Value 2021-2025 ($ Millions)
Figure 101. Europe All Vaccine Consumption 2021-2025 (M Dose)
Figure 102. Europe All Vaccine Value 2021-2025 ($ Millions)
Figure 103. Middle East & Africa All Vaccine Consumption 2021-2025 (M Dose)
Figure 104. Middle East & Africa All Vaccine Value 2021-2025 ($ Millions)
Figure 105. United States All Vaccine Consumption 2021-2025 (M Dose)
Figure 106. United States All Vaccine Value 2021-2025 ($ Millions)
Figure 107. Canada All Vaccine Consumption 2021-2025 (M Dose)
Figure 108. Canada All Vaccine Value 2021-2025 ($ Millions)
Figure 109. Mexico All Vaccine Consumption 2021-2025 (M Dose)
Figure 110. Mexico All Vaccine Value 2021-2025 ($ Millions)
Figure 111. Brazil All Vaccine Consumption 2021-2025 (M Dose)
Figure 112. Brazil All Vaccine Value 2021-2025 ($ Millions)
Figure 113. China All Vaccine Consumption 2021-2025 (M Dose)
Figure 114. China All Vaccine Value 2021-2025 ($ Millions)
Figure 115. Japan All Vaccine Consumption 2021-2025 (M Dose)
Figure 116. Japan All Vaccine Value 2021-2025 ($ Millions)
Figure 117. Korea All Vaccine Consumption 2021-2025 (M Dose)
Figure 118. Korea All Vaccine Value 2021-2025 ($ Millions)
Figure 119. Southeast Asia All Vaccine Consumption 2021-2025 (M Dose)
Figure 120. Southeast Asia All Vaccine Value 2021-2025 ($ Millions)
Figure 121. India All Vaccine Consumption 2021-2025 (M Dose)
Figure 122. India All Vaccine Value 2021-2025 ($ Millions)
Figure 123. Australia All Vaccine Consumption 2021-2025 (M Dose)
Figure 124. Australia All Vaccine Value 2021-2025 ($ Millions)
Figure 125. Germany All Vaccine Consumption 2021-2025 (M Dose)
Figure 126. Germany All Vaccine Value 2021-2025 ($ Millions)
Figure 127. France All Vaccine Consumption 2021-2025 (M Dose)
Figure 128. France All Vaccine Value 2021-2025 ($ Millions)
Figure 129. UK All Vaccine Consumption 2021-2025 (M Dose)
Figure 130. UK All Vaccine Value 2021-2025 ($ Millions)
Figure 131. Italy All Vaccine Consumption 2021-2025 (M Dose)
Figure 132. Italy All Vaccine Value 2021-2025 ($ Millions)
Figure 133. Russia All Vaccine Consumption 2021-2025 (M Dose)
Figure 134. Russia All Vaccine Value 2021-2025 ($ Millions)
Figure 135. Spain All Vaccine Consumption 2021-2025 (M Dose)
Figure 136. Spain All Vaccine Value 2021-2025 ($ Millions)
Figure 137. Egypt All Vaccine Consumption 2021-2025 (M Dose)
Figure 138. Egypt All Vaccine Value 2021-2025 ($ Millions)
Figure 139. South Africa All Vaccine Consumption 2021-2025 (M Dose)
Figure 140. South Africa All Vaccine Value 2021-2025 ($ Millions)
Figure 141. Israel All Vaccine Consumption 2021-2025 (M Dose)
Figure 142. Israel All Vaccine Value 2021-2025 ($ Millions)
Figure 143. Turkey All Vaccine Consumption 2021-2025 (M Dose)
Figure 144. Turkey All Vaccine Value 2021-2025 ($ Millions)
Figure 145. GCC Countries All Vaccine Consumption 2021-2025 (M Dose)
Figure 146. GCC Countries All Vaccine Value 2021-2025 ($ Millions)
Figure 147. CNBG All Vaccine Market Share (2018-2020)
Figure 148. Novartis All Vaccine Market Share (2018-2020)
Figure 149. ChengDa Bio All Vaccine Market Share (2018-2020)
Figure 150. Zhifei All Vaccine Market Share (2018-2020)
Figure 151. SINOVAC BIOTECH All Vaccine Market Share (2018-2020)
Figure 152. Changsheng Life All Vaccine Market Share (2018-2020)
Figure 153. Kangtai All Vaccine Market Share (2018-2020)
Figure 154. NuoCheng Bio All Vaccine Market Share (2018-2020)
Figure 155. SANOFI PASTEUR All Vaccine Market Share (2018-2020)
Figure 156. Hualan Bio All Vaccine Market Share (2018-2020)
Figure 157. GSK All Vaccine Market Share (2018-2020)
※본 조사보고서 [세계의 백신 시장예측 2020년-2025년] (코드 : LPI20KJU00316) 판매에 관한 면책사항을 반드시 확인하세요.
※본 조사보고서 [세계의 백신 시장예측 2020년-2025년] 에 대해서 E메일 문의는 여기를 클릭하세요.